Consolidated Income Statement

(in € million, except per share amounts)	Years ended December 31
(in € million, except per share amounts)	2017	2016	2015
Net revenues	110,934	111,018	110,595
Cost of revenues	93,975	95,295	97,620
Selling, general and other costs	7,385	7,568	7,576
Research and development costs	3,230	3,274	2,864
Result from investments:	410	316	143
Share of the profit of equity method investees	409	313	130
Other income from investments	1	3	13
Reversal of a Brazilian indirect tax liability	895	---	---
Gains on disposal of investments	76	13	---
Restructuring costs	95	88	53
Net financial expenses	1,469	2,016	2,366
Profit before taxes	6,161	3,106	259
Tax expense	2,651	1,292	166
Net profit from continuing operations	3,510	1,814	93
Profit from discontinued operations, net of tax	---	---	284
Net profit	3,510	1,814	377

Net profit attributable to:
Owners of the parent	3,491	1,803	334
Non-controlling interests	19	11	43
	3,510	1,814	377
Net profit from continuing operations attributable to:
Owners of the parent	3,491	1,803	83
Non-controlling interests	19	11	10
	3,510	1,814	93
Earnings per share:
Basic earnings per share	2.27	1.19	0.22
Diluted earnings per share	2.24	1.18	0.22

Earnings per share for Net profit from continuing operations:
Basic earnings per share	2.27	1.19	0.05
Diluted earnings per share	2.24	1.18	0.05

Consolidated Statement
of Comprehensive Income

(in € million)	Years ended December 31
(in € million)	2017	2016	2015
Net profit (A)	3,510	1,814	377

Items that will not be reclassified to the Consolidated Income Statement in subsequent periods:
(Losses)/gains on re-measurement of defined benefit plans	(64)	584	679
Share of gains/(losses) on re-measurement of defined benefit plans for equity method investees	2	(5)	(2)
Related tax impact	(21)	(261)	(201)
Items relating to discontinued operations, net of tax	---	---	3
Total items that will not be reclassified to the Consolidated Income Statement in subsequent periods (B1)	(83)	318	479

Items that may be reclassified to the Consolidated Income Statement in subsequent periods:
Gains/(losses) on cash flow hedging instruments	147	(249)	186
Gains on available-for-sale financial assets	14	15	11
Exchange (losses)/gains on translating foreign operations	(1,942)	458	1,002
Share of Other comprehensive (loss) for equity method investees	(121)	(122)	(17)
Related tax impact	(10)	69	(48)
Items relating to discontinued operations, net of tax	---	---	18
Total items that may be reclassified to the Consolidated Income Statement in subsequent periods (B2)	(1,912)	171	1,152

Total Other comprehensive (loss)/income, net of tax (B1)+(B2)=(B)	(1,995)	489	1,631

Total Comprehensive income (A)+(B)	1,515	2,303	2,008

Total Comprehensive income attributable to:
Owners of the parent	1,491	2,288	1,953
Non-controlling interests	24	15	55
	1,515	2,303	2,008
Total Comprehensive income attributable to owners of the parent:	1,491	2,288	1,685
Continuing operations	1,491	2,288	1,685
Discontinued operations	---	---	268
	1,491	2,288	1,953

Consolidated Income Statement

Consolidated Statement of Comprehensive Income

Consolidated Statement
of Comprehensive Income